Armata Pharmaceuticals

ARMPNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$111.174 M

$2.99 -4.78%

Close of 6 Nov 2026

As of 6 Nov 2026, Armata Pharmaceuticals (ARMP) has a market capitalization of $111.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$173.8M

Loss-making

Shares outstanding

37,181,979

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#106enGene TherapeuticsENGN$113.6M
#107Cardiol TherapeuticsCRDL$112.1M
#108Armata PharmaceuticalsARMP$111.2M
#109HumacyteHUMA$108.3M
#110Outlook TherapeuticsOTLK$107.3M

What if Armata Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$759,423.64

Per share 253,988× higher

Bitcoin $1.53T

$41,091.09

Per share 13,743× higher

Apple $5.02T

$134,898.22

Per share 45,116× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Armata Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.